Feds Urge Cuts in Use of Anti-Psychotic Drugs for Seniors

Medicare officials seek to reduce the off-label use of a handful of medications to subdue agitated seniors with dementia. The drugs are not only bad for patients—they can also trigger outcomes that hurt hospital reimbursement.

Name:
E-mail:
Website:
Please enter your comment below:

Please enter the text below: